Back to Search
DONALD SWEENEY, PHARM.D., MBA
PHARM.D., MBA
Pharmacist
NPI: 1598119554Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Recombinant human activated protein C, package labeling, and hemorrhage risks.
PMID 19112285·Crit Care Med·2009
8-other
Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?
PMID 19318828·Crit Care Med·2009
8-other
Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors.
PMID 19616798·J Urol·2009
4-observational
Factor analytic study of repetitive behaviours in young children with Pervasive Developmental Disorders.
PMID 19148740·J Autism Dev Disord·2009
8-other
Prediction of and experimental support for the three-dimensional structure of replication protein A.
PMID 19621872·Biochemistry·2009
4-observational
Best practice contact lens care: a review of the Asia Pacific Contact Lens Care Summit.
PMID 19278458·Clin Exp Optom·2009
8-other
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
PMID 19528279·Antimicrob Agents Chemother·2009
8-other
The effect of long-term wear of soft lenses of low and high oxygen transmissibility on the corneal epithelium.
PMID 18849917·Eye (Lond)·2009
8-other
Sleep problems of parents of typically developing children and parents of children with autism.
PMID 18788326·J Genet Psychol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1579 SUNFLOWER CIR
TUPELO, MS 38801 - Phone
- (662) 416-1001
Quick Facts
- NPI
- 1598119554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile